Lexeo Therapeutics Inc.

NASDAQ:LXEO   4:00:00 PM EDT
3.96
+0.05 (+1.28%)
7:15:30 PM EDT: $3.98 +0.02 (+0.51%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Lexeo Therapeutics Inc. Stock, NASDAQ:LXEO

345 Park Avenue South, 6th floor, New York, New York 10010
United States of America
Phone: +1.212.547.9879
Number of Employees: 58
http://www.lexeotx.com

Description

Lexeo Therapeutics, Inc. is a clinical stage genetic medicine company, which engages in the development of therapies for hereditary and acquired diseases. The firm focuses on the medication of genetically defined cardiovascular diseases and sub-group of Alzheimer�s disease. It offers LX2006 for the treatment of patients with Friedreich's ataxia, cardiomyopathy, and LX1001 for APOE4 homozygous patients with Alzheimer's disease. The company was founded by Ronald G. Crystal in February 2017 and is headquartered in New York, NY.